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Key PointsGut‐focused hypnotherapy is highly effective in functional gastrointestinal disorders when conventional treatments have failed.While the exact mechanisms remain elusive, hypnotherapy appears to modulate brain‐gut pain pathways and sensorimotor function.Hypnotherapy significantly improves symptoms in up to 76% of patients with durable effects and important socioeconomic benefits.

1. INTRODUCTION {#nmo13573-sec-0004}
===============

Functional gastrointestinal disorders (FGIDs) are the most common diagnoses in gastroenterology[1](#nmo13573-bib-0001){ref-type="ref"}, [2](#nmo13573-bib-0002){ref-type="ref"} with a reported population prevalence of 35%.[3](#nmo13573-bib-0003){ref-type="ref"} Based on advances in the understanding of FGIDs and their pathophysiology over the past two decades, these are now defined as disorders of \'*Gut‐brain interaction\'*.[4](#nmo13573-bib-0004){ref-type="ref"} The hallmark of these conditions is gastrointestinal symptoms related to any combination of: motility disturbance, visceral hypersensitivity, altered mucosal and immune function, altered gut microbiota, and altered central nervous system processing.[1](#nmo13573-bib-0001){ref-type="ref"} While the recent Rome IV classification for FGIDs has described 33 separate entities covering six different anatomical regions,[1](#nmo13573-bib-0001){ref-type="ref"} it is recognized that there is significant overlap between these disorders.[3](#nmo13573-bib-0003){ref-type="ref"}, [5](#nmo13573-bib-0005){ref-type="ref"} Unfortunately, despite progress in making positive diagnoses,[6](#nmo13573-bib-0006){ref-type="ref"} physiological testing[7](#nmo13573-bib-0007){ref-type="ref"} and understanding of gut‐brain interactions, treatment remains challenging[8](#nmo13573-bib-0008){ref-type="ref"}. Moreover, patient satisfaction with medical treatment is disappointingly low,[9](#nmo13573-bib-0009){ref-type="ref"} with many patients failing to improve despite being prescribed a wide variety of conventional therapies. It is estimated that around a quarter of patients have severe, refractory symptoms, with significant impairment of quality of life (QoL), detrimental effects on daily functioning, personal and social relationships, workplace productivity, and psychological well‐being including suicidal ideation.[10](#nmo13573-bib-0010){ref-type="ref"}, [11](#nmo13573-bib-0011){ref-type="ref"}, [12](#nmo13573-bib-0012){ref-type="ref"}, [13](#nmo13573-bib-0013){ref-type="ref"}, [14](#nmo13573-bib-0014){ref-type="ref"}, [15](#nmo13573-bib-0015){ref-type="ref"}, [16](#nmo13573-bib-0016){ref-type="ref"}, [17](#nmo13573-bib-0017){ref-type="ref"} These patients are also vulnerable to iatrogenic harm including repeatedly negative investigations, opiate analgesia, and unnecessary surgical interventions,[18](#nmo13573-bib-0018){ref-type="ref"}, [19](#nmo13573-bib-0019){ref-type="ref"}, [20](#nmo13573-bib-0020){ref-type="ref"} not to mention the associated spiraling healthcare costs.[21](#nmo13573-bib-0021){ref-type="ref"} Perhaps unsurprisingly, when we consider the current pathophysiological understanding of FGIDs, among all the heterogeneous treatment options available, approaches targeting *\'gut‐brain interactions\'* including centrally acting neuromodulators[22](#nmo13573-bib-0022){ref-type="ref"}, [23](#nmo13573-bib-0023){ref-type="ref"} and behavioral approaches such as gut‐focused hypnotherapy[24](#nmo13573-bib-0024){ref-type="ref"} have shown the most promise. Indeed, mounting evidence and clinical experience from tertiary centers, including our own center in Manchester over the past 35 years, have shown that gut‐focused hypnotherapy can improve symptoms, even in severe, refractory cases, by modulating some of the key pathophysiological processes including visceral pain sensitivity and motility[25](#nmo13573-bib-0025){ref-type="ref"} and can improve coping, resilience, self‐regulation skills[26](#nmo13573-bib-0026){ref-type="ref"} and reduce healthcare utilization.[27](#nmo13573-bib-0027){ref-type="ref"}, [28](#nmo13573-bib-0028){ref-type="ref"} Despite initial skepticism, there is now increased interest in the role of hypnotherapy in the area of FGIDs. However, the literature on the subject remains relatively sparse with only 384 peer‐reviewed papers being identified in a PubMed search in November 2018 using the search terms \'functional gastrointestinal disorders\' and \'hypnotherapy' with the \'AND\' operator. Despite this, there are now several high‐quality systematic reviews,[24](#nmo13573-bib-0024){ref-type="ref"}, [29](#nmo13573-bib-0029){ref-type="ref"}, [30](#nmo13573-bib-0030){ref-type="ref"} demonstrating that it is an effective option for refractory/severe symptoms in patients with FGIDs. Moreover, the pivotal role of the gastroenterologist in making a strong and compelling recommendation for appropriate patients to have this effective therapy has recently been highlighted.[31](#nmo13573-bib-0031){ref-type="ref"} In this context, the aim of this review article is to provide a state of the art overview of the evidence‐base and practical aspects of gut‐focused hypnotherapy as a primer for gastroenterologists looking after patients with severe FGIDs.

2. THE HISTORY AND PRINCIPLES OF GUT‐FOCUSED HYPNOTHERAPY {#nmo13573-sec-0005}
=========================================================

2.1. Myths and misperceptions {#nmo13573-sec-0006}
-----------------------------

Gut‐focused hypnotherapy has been used as a treatment for refractory, severe FGIDs since the early 1980 s.[32](#nmo13573-bib-0032){ref-type="ref"} Unfortunately, uptake among some clinicians and patients has been hindered by the common misperception of hypnosis, which carries an erroneous legacy of mystery and coercive influence over people from popular media and stage shows.[33](#nmo13573-bib-0033){ref-type="ref"} Indeed, recent data from our own unit has shown that over half of patients referred for gut‐focused hypnotherapy have negative perceptions about treatment before, but not after, treatment.[34](#nmo13573-bib-0034){ref-type="ref"} Fortunately, negative perceptions pretreatment did not appear to influence the chances of a clinical response.[34](#nmo13573-bib-0034){ref-type="ref"}

2.2. The aims and principles of gut‐focused hypnotherapy {#nmo13573-sec-0007}
--------------------------------------------------------

Hypnotherapy is usually carried out on an individualized basis by a trained therapist during 30‐60 minute sessions, at weekly intervals, for 6‐12 weeks. Clinical hypnosis is a verbal intervention that utilizes a special mental state of enhanced receptivity to suggestion, to facilitate therapeutic psychological and physiological changes.[35](#nmo13573-bib-0035){ref-type="ref"} Broadly, the aims of gut‐focused hypnotherapy are to induce a deep state of relaxation to guide the patient to learn how to control their gut function. The first session is typically an introductory session. One of the fundamental aspects of delivering a gut‐focused hypnotherapy package for a functional disorder is educating the patient regarding the basic anatomy and physiology of the gut. This is provided in a way that is easily understandable at the outset. The patient is then provided with explanations about how disturbance of this normal gastrointestinal \'function\' can produce their specific symptoms. Previous studies have shown the benefits of optimizing gut‐focused hypnotherapy based on patients' personal visual imagery of their functional disorder,[36](#nmo13573-bib-0036){ref-type="ref"} using color,[37](#nmo13573-bib-0037){ref-type="ref"}, [38](#nmo13573-bib-0038){ref-type="ref"} illustrations and anatomical diagrams[39](#nmo13573-bib-0039){ref-type="ref"}, [40](#nmo13573-bib-0040){ref-type="ref"} to enhance the treatment experience (Figure [1](#nmo13573-fig-0001){ref-type="fig"}). During subsequent hypnotherapy sessions, the patient is taught a series of approaches to enable them to gain control of their gut function. The approach is adapted to the patients' symptom profile and own personal imagery using metaphors. For example, patients with a functional bowel disorder could be asked to imagine their gut as a river and modify its flow according to their needs depending on whether they have predominant diarrhea or constipation.[25](#nmo13573-bib-0025){ref-type="ref"} For abdominal pain, the tactile approach of the patient placing their hand on their abdomen, feeling warmth, and using this to alleviate pain can be useful.[25](#nmo13573-bib-0025){ref-type="ref"} Similarly, an inflated balloon being slowly deflated can be used as a metaphor to reduce abdominal bloating. This is also sometimes combined with other helpful techniques such as teaching the patient diaphragmatic breathing.

![Examples of illustrations and visual imagery to represent functional gastrointestinal symptoms to enhance the hypnotherapy experience (Reproduced and adapted with permission from Carruthers HR, Morris J, Tarrier N, Whorwell PJ. Reactivity to images in health and irritable bowel syndrome. *Aliment Pharmacol Ther* 2010; 31:131--142)](NMO-31-na-g001){#nmo13573-fig-0001}

During hypnotherapy sessions, great emphasis is placed on the patient having control of their gut, rather than their gut having control over them, a mantra which is reinforced repeatedly.[25](#nmo13573-bib-0025){ref-type="ref"} While the content of sessions is similar, therapists often introduce suggestions and strategies on how to overcome tendencies to anxiety or fear of imminent catastrophe and developing the ability to gain control over other coincidental problems.[25](#nmo13573-bib-0025){ref-type="ref"} Patients are encouraged to practice hypnotherapy at home in between sessions using audio recordings.

For further information on the practical delivery of gut‐focused hypnotherapy, please find our hypnotherapy protocol, with an example of a hypnotherapy script, in the supplementary file linked to this paper (Data [S1](#nmo13573-sup-0001){ref-type="supplementary-material"}).

3. GUT‐FOCUSED HYPNOTHERAPY AND EFFECTS ON GUT‐BRAIN INTERACTIONS {#nmo13573-sec-0008}
=================================================================

3.1. Effects of hypnosis on gastrointestinal motility and function {#nmo13573-sec-0009}
------------------------------------------------------------------

While the exact mechanisms of gut‐focused hypnotherapy in functional FGIDs are not fully understood, a number of studies have demonstrated its ability to induce changes in gastrointestinal function and physiology. For example, in the upper gastrointestinal tract, hypnotherapy has been shown to be able to modulate gastric acid secretion,[41](#nmo13573-bib-0041){ref-type="ref"} accelerate gastric emptying,[42](#nmo13573-bib-0042){ref-type="ref"} and alter orocecal transit time measured using the lactulose hydrogen breath test,[43](#nmo13573-bib-0043){ref-type="ref"} in controlled studies in healthy participants. Similarly, in the lower gastrointestinal tract, some studies conducted in patients with Irritable Bowel Syndrome (IBS) have shown appreciable differences in colonic sensory and motor function before and immediately after hypnotherapy, demonstrating modulation of postprandial gastrocolic reflex activity,[44](#nmo13573-bib-0044){ref-type="ref"} colonic motility,[45](#nmo13573-bib-0045){ref-type="ref"} and visceral hypersensitivity.[44](#nmo13573-bib-0044){ref-type="ref"}, [46](#nmo13573-bib-0046){ref-type="ref"}, [47](#nmo13573-bib-0047){ref-type="ref"}, [48](#nmo13573-bib-0048){ref-type="ref"} In an interesting study of the effects of hypnotherapy on gastrointestinal motility in a heterogeneous group of IBS patients, Lindfors et al did not detect any significant long‐term differences in gastric emptying, small intestinal transit time, antroduodenal manometry or colonic transit time before and after hypnotherapy.[49](#nmo13573-bib-0049){ref-type="ref"} However, the inclusion of patients with both constipation and diarrhea predominant IBS in this study[49](#nmo13573-bib-0049){ref-type="ref"} makes the motility and transit data difficult to interpret, given the differing therapeutic approaches to gut‐focused hypnotherapy between the two IBS subtypes and the potential opposing effects on these metrics that the differing approaches to hypnotherapy may have.

3.2. Putative mechanisms of action of gut‐focused hypnotherapy {#nmo13573-sec-0010}
--------------------------------------------------------------

As alluded to earlier, while the exact mechanisms of action of gut‐focused hypnotherapy remain unclear, a number of studies using functional brain imaging techniques have given some plausible explanations which suggest that hypnotherapy can induce changes in neuroplasticity. For example, several studies have investigated brain activity in response to painful visceral stimuli in IBS.[50](#nmo13573-bib-0050){ref-type="ref"} Based on this work, and other studies, current understanding is that patients with painful FGIDs have abnormal signaling in visceral afferent pathways and central pain amplification.[51](#nmo13573-bib-0051){ref-type="ref"} Interestingly, the anterior cingulate cortex, one of the brain regions most consistently enhanced by painful visceral stimuli in IBS,[52](#nmo13573-bib-0052){ref-type="ref"}, [53](#nmo13573-bib-0053){ref-type="ref"}, [54](#nmo13573-bib-0054){ref-type="ref"} has been shown to be an area which can be modulated by hypnotherapy during treatment focused on altering the response to a noxious painful stimulus (Figure [2](#nmo13573-fig-0002){ref-type="fig"}).[55](#nmo13573-bib-0055){ref-type="ref"} Studies of hypnotherapy in the chronic pain literature have shown that hypnotic suggestions for pain modulation also impact the prefrontal, insular, and somatosensory regions, and there is evidence for differing brain activations depending on whether the hypnotic suggestion is related to pain affect or pain intensity.[56](#nmo13573-bib-0056){ref-type="ref"} Moreover, a recent, well‐designed, controlled study has shown that responders to hypnotherapy with moderate to severe IBS had attenuation of brain activity in the posterior insula and that improvement in symptoms was associated with normalization of evoked brain responses to painful visceral stimuli (Figure [3](#nmo13573-fig-0003){ref-type="fig"}).[57](#nmo13573-bib-0057){ref-type="ref"} These data suggest that the use of gut‐focused metaphors, hypnotic suggestions for physiological improvement, and imagery used during hypnotherapy, may select specific related peripheral and central gut‐brain neuronal pathways, leading to favorable neuroplastic changes induced by practice and further re‐enforcement during, and in between hypnotherapy sessions. This would perhaps explain the functional, physiological and clinically relevant benefits that have been observed following hypnotherapy, which may drive such neuroplastic changes to restore \'normal\' processing of painful visceral stimuli in patients with FGIDs.

![Hypnotherapy induced changes in pain‐related brain activation in the Anterior Cingulate Cortex (ACC) seen on Positron Emission Topography. Hypnotic suggestions of low unpleasantness of pain evoke less activity in ACC compared to highly unpleasant hypnotic suggestions of pain (Reproduced with permission from Rainville P, Duncan GH, Price DD, Carrier Bt, Bushnell MC. Pain Affect Encoded in Human Anterior Cingulate But Not Somatosensory Cortex. *Science* 1997; 277:968--971)](NMO-31-na-g002){#nmo13573-fig-0002}

![Hypnotherapy restores a normal pattern of brain activity evoked by high‐intensity rectal distension in IBS patients (Reproduced with permission from Lowén, A. ME, et al Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. *Alimentary Pharmacology & Therapeutics* 2013; 37:1184--1197)](NMO-31-na-g003){#nmo13573-fig-0003}

4. HYPNOTHERAPY IN IRRITABLE BOWEL SYNDROME: A MODEL FOR OTHER FUNCTIONAL DISORDERS {#nmo13573-sec-0011}
===================================================================================

IBS, the most common FGID,[3](#nmo13573-bib-0003){ref-type="ref"} is defined by recurrent abdominal pain associated with defecation or a change in bowel habit and abdominal bloating/distension.[58](#nmo13573-bib-0058){ref-type="ref"} Unsurprisingly, given its high prevalence, it has been the subject of the most research since gut‐focused hypnotherapy was introduced for FGIDs in the 1980 s.[59](#nmo13573-bib-0059){ref-type="ref"} Given the common, overlapping features and characteristics of FGIDs, IBS has proved to be an ideal model for understanding how hypnotherapy can be applied to the investigation and management of other functional disorders.

4.1. Patient selection and clinical indications {#nmo13573-sec-0012}
-----------------------------------------------

It is important to ensure a firm clinical diagnosis of IBS is established prior to considering hypnotherapy. Hypnotherapy is indicated for patients with severe symptoms refractory to 12 months of pharmacological treatment.[60](#nmo13573-bib-0060){ref-type="ref"}, [61](#nmo13573-bib-0061){ref-type="ref"} In recent years, dietary interventions have been shown to play a significant role in treating FGIDs. There is now a strong body of evidence for exclusion diets and the low fermentable oligo‐, di‐, and monosaccharides and polyols (FODMAPs) diet, which have been shown to improve symptoms in 40%‐50% of patients.[62](#nmo13573-bib-0062){ref-type="ref"}, [63](#nmo13573-bib-0063){ref-type="ref"}, [64](#nmo13573-bib-0064){ref-type="ref"} These dietary interventions are recommended as first‐line therapy for IBS.[60](#nmo13573-bib-0060){ref-type="ref"}, [65](#nmo13573-bib-0065){ref-type="ref"} Indeed, a small randomized study from Australia compared outcomes from first‐line therapy with six weeks of hypnotherapy versus a low‐FODMAPs diet, and a combination of the two approaches, and found all three to be equally effective in improving symptoms.[66](#nmo13573-bib-0066){ref-type="ref"} These data support current recommendations to use dietary interventions such as the low‐FODMAPs diet as first‐line and reserving gut‐focused hypnotherapy for more severe, refractory cases, where all conventional measures have failed. In practice, most patients referred for hypnotherapy for IBS have, therefore, usually tried the low‐FODMAPs diet. It is important that hypnotherapy is not considered a standalone treatment, and the package of care offered should include dietary modifications to improve the chances of a successful outcome.[65](#nmo13573-bib-0065){ref-type="ref"}

Patient age appears to account for very little of the variance in clinical outcomes to gut‐focused hypnotherapy[67](#nmo13573-bib-0067){ref-type="ref"} and therefore should not be a barrier to accessing gut‐focused hypnotherapy. Indeed, there is evidence showing that the efficacy of gut‐focused hypnotherapy in children and adolescents with IBS is similar to that in adults,[68](#nmo13573-bib-0068){ref-type="ref"}, [69](#nmo13573-bib-0069){ref-type="ref"}, [70](#nmo13573-bib-0070){ref-type="ref"}, [71](#nmo13573-bib-0071){ref-type="ref"}, [72](#nmo13573-bib-0072){ref-type="ref"} with long‐term benefits.[73](#nmo13573-bib-0073){ref-type="ref"} While our experience suggests that the magnitude of clinical response in those over 50 years of age is less than that seen in younger patients,[71](#nmo13573-bib-0071){ref-type="ref"}, [74](#nmo13573-bib-0074){ref-type="ref"} 74% of those above the age of 50 still achieve a clinically meaningful improvement (50 point reduction in IBS symptom severity scores);[74](#nmo13573-bib-0074){ref-type="ref"} therefore, hypnotherapy is certainly still worth considering in this group, particularly in refractory cases where other conventional treatments have failed.

However, it is important to note that hypnotherapy is not appropriate in all patients and caution should be exercised in patients with significant psychopathologies.

4.2. Clinical efficacy in Irritable Bowel Syndrome {#nmo13573-sec-0013}
--------------------------------------------------

The earliest randomized study of hypnotherapy for IBS demonstrated significant improvement in abdominal pain, abdominal bloating, and bowel function following hypnosis, compared to supportive therapy with a placebo medication.[59](#nmo13573-bib-0059){ref-type="ref"} Subsequent studies have not only replicated this,[59](#nmo13573-bib-0059){ref-type="ref"}, [67](#nmo13573-bib-0067){ref-type="ref"}, [74](#nmo13573-bib-0074){ref-type="ref"}, [75](#nmo13573-bib-0075){ref-type="ref"}, [76](#nmo13573-bib-0076){ref-type="ref"}, [77](#nmo13573-bib-0077){ref-type="ref"}, [78](#nmo13573-bib-0078){ref-type="ref"}, [79](#nmo13573-bib-0079){ref-type="ref"}, [80](#nmo13573-bib-0080){ref-type="ref"}, [81](#nmo13573-bib-0081){ref-type="ref"}, [82](#nmo13573-bib-0082){ref-type="ref"}, [83](#nmo13573-bib-0083){ref-type="ref"} but several have demonstrated that gut‐focused hypnotherapy has potential wider socioeconomic benefits including improving general well‐being, reduction in healthcare utilization,[75](#nmo13573-bib-0075){ref-type="ref"}, [84](#nmo13573-bib-0084){ref-type="ref"}, [85](#nmo13573-bib-0085){ref-type="ref"} improved QoL[67](#nmo13573-bib-0067){ref-type="ref"}, [83](#nmo13573-bib-0083){ref-type="ref"}, [85](#nmo13573-bib-0085){ref-type="ref"}, [86](#nmo13573-bib-0086){ref-type="ref"} and presenteeism at work.[75](#nmo13573-bib-0075){ref-type="ref"} Moreover, in addition to bowel symptoms, patients with IBS are known to suffer from multiple extra‐intestinal symptoms including: nausea, thigh pain, low backache, lethargy, and a range of urinary and gynecological symptoms.[87](#nmo13573-bib-0087){ref-type="ref"} These symptoms are notoriously difficult to treat and seldom respond to conventional treatments for IBS. However, these extra‐intestinal symptoms have also been shown to improve with gut‐focused hypnotherapy[67](#nmo13573-bib-0067){ref-type="ref"}, [74](#nmo13573-bib-0074){ref-type="ref"}, [75](#nmo13573-bib-0075){ref-type="ref"} and improvement in anxiety and depression levels[67](#nmo13573-bib-0067){ref-type="ref"}, [74](#nmo13573-bib-0074){ref-type="ref"}, [79](#nmo13573-bib-0079){ref-type="ref"}, [85](#nmo13573-bib-0085){ref-type="ref"}, [86](#nmo13573-bib-0086){ref-type="ref"} and cognitive function.[88](#nmo13573-bib-0088){ref-type="ref"} Furthermore, the effects of hypnotherapy are long lasting,[84](#nmo13573-bib-0084){ref-type="ref"}, [85](#nmo13573-bib-0085){ref-type="ref"} associated with high levels of patient satisfaction[86](#nmo13573-bib-0086){ref-type="ref"} and reduced medication use.[85](#nmo13573-bib-0085){ref-type="ref"}, [89](#nmo13573-bib-0089){ref-type="ref"} In a recent, large cohort study of 1000 adult patients with refractory IBS, 76% of patients achieved a response (defined as a 50 point improvement in the IBS symptom severity score) following gut‐focused hypnotherapy (Figure [4](#nmo13573-fig-0004){ref-type="fig"}), with higher response rates in females 80% compared to 62% in males.[74](#nmo13573-bib-0074){ref-type="ref"}

![IBS Symptom Severity Scores before and after gut‐focused hypnotherapy in the largest cohort to date (*n* = 1,000) (Reproduced with permission from Miller V, Carruthers HR, Morris J, Hasan SS, Archbold S, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. *Aliment Pharmacol Ther* 2015; 41:844--855)](NMO-31-na-g004){#nmo13573-fig-0004}

5. GUT‐FOCUSED HYPNOTHERAPY IN FUNCTIONAL UPPER GASTROINTESTINAL DISORDERS {#nmo13573-sec-0014}
==========================================================================

As described earlier in this paper, there is considerable overlap in the pathophysiology of FGIDs, with studies in both upper and lower FGIDs consistently demonstrating visceral hypersensitivity to mechanical or chemical stimuli.[90](#nmo13573-bib-0090){ref-type="ref"}, [91](#nmo13573-bib-0091){ref-type="ref"} Indeed, there is emerging evidence that \'esophagus‐focused hypnotherapy\' is both feasible and acceptable to patients with functional esophageal disorders.[92](#nmo13573-bib-0092){ref-type="ref"}, [93](#nmo13573-bib-0093){ref-type="ref"} Importantly, the recently updated diagnostic criteria for this group of disorders reflect advances in motility diagnostics.[94](#nmo13573-bib-0094){ref-type="ref"} These robust criteria, therefore, ensure that all patients, by definition, will have had all the necessary structural endoscopic/radiological, pH/impedance monitoring and motility investigations where appropriate. Similar to findings in IBS patients, patients with normal esophageal physiology and refractory functional esophageal symptoms have recently been shown to have impaired quality of life and high levels of psychosocial distress.[95](#nmo13573-bib-0095){ref-type="ref"} The principles of esophageal‐focused hypnotherapy in this group of patients mirror the approaches used in IBS, but specifically target esophageal hypervigilance and esophageal hypersensitivity.[90](#nmo13573-bib-0090){ref-type="ref"} This is usually achieved using visual imagery around esophageal physiology and metaphoric imagery related to esophageal symptoms using structured, scripted protocols.[90](#nmo13573-bib-0090){ref-type="ref"} In globus pharyngeus, 7 sessions of this type of hypnotherapy significantly reduced globus symptoms with response in 9 out of 10 patients without altering upper esophageal sphincter pressures.[93](#nmo13573-bib-0093){ref-type="ref"} Similarly, in functional heartburn, 9 patients who completed 7 weekly sessions of hypnosis, all reported symptomatic improvement including visceral anxiety and QoL.[92](#nmo13573-bib-0092){ref-type="ref"} Functional chest pain, defined as recurring, unexplained retrosternal pain of presumed esophageal origin, requires prior exclusion of coronary artery disease with appropriate cardiological investigations,[94](#nmo13573-bib-0094){ref-type="ref"} is a particularly debilitating condition associated with high psychological morbidity. Hypnotherapy in a randomized controlled study in non‐cardiac chest pain patients with normal coronary angiography (n = 28) demonstrated reduction of global pain scores in 12/15 patients (80%) compared to only 23% response in controls (supportive treatment plus placebo medication).[96](#nmo13573-bib-0096){ref-type="ref"} Twelve sessions of hypnotherapy also improved well‐being, QoL, reduced pain intensity, and medication use, with long‐lasting effects maintained at 2 years posthypnotherapy (Figure [5](#nmo13573-fig-0005){ref-type="fig"}).[96](#nmo13573-bib-0096){ref-type="ref"}, [97](#nmo13573-bib-0097){ref-type="ref"}

![Short‐ and long‐term benefits of gut‐focused hypnotherapy in non‐cardiac chest pain compared to supportive therapy (Reproduced with permission from Miller V, Jones H, Whorwell PJ. Hypnotherapy for non‐cardiac chest pain: long‐term follow‐up. *Gut* 2007; 56:1643)](NMO-31-na-g005){#nmo13573-fig-0005}

Functional Dyspepsia (FD), another relatively common FGID which significantly impacts activities of daily living, is defined by one or more of the following symptoms: postprandial fullness, early satiation, epigastric pain, and burning, in the absence of structural abnormalities.[98](#nmo13573-bib-0098){ref-type="ref"} Gut‐focused hypnotherapy can also be customized for FD by targeting gastroduodenal function and symptoms. This can involve both tactile and imagery techniques with suggestions of positive changes in motor activity, sensitivity, and secretion of acid. This approach has been shown to be highly effective in a randomized controlled trial which demonstrated that 16 weeks of hypnotherapy was superior to both supportive care and medical therapy, with 73% response rates at 12 months (Figure [6](#nmo13573-fig-0006){ref-type="fig"}) and wider socioeconomic benefits including reduced consultation rates and lower medication use when compared to both the control groups.[99](#nmo13573-bib-0099){ref-type="ref"}

![The efficacy of gut‐focused hypnotherapy compared to medical therapy and supportive care in Functional Dyspepsia (Reproduced with permission from Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ. Long‐term improvement in functional dyspepsia using hypnotherapy. *Gastroenterology* 2002; 123:1778--1785)](NMO-31-na-g006){#nmo13573-fig-0006}

6. CENTRALLY MEDIATED ABDOMINAL PAIN {#nmo13573-sec-0015}
====================================

Centrally mediated abdominal pain syndrome (CAPS) is a recently redefined, relatively rare but severe FGID, which is defined as chronic continuous abdominal pain that is minimally related to the physiological events of eating, defecation, and menses and results in a loss of day‐to‐day functioning.[100](#nmo13573-bib-0100){ref-type="ref"} While poorly understood, the mechanism of pain in these disorders is postulated to be due to central sensitization.[51](#nmo13573-bib-0051){ref-type="ref"}, [101](#nmo13573-bib-0101){ref-type="ref"} CAPS is a challenging condition to treat with patients often presenting repeatedly with significant psychological comorbidity, multiple repeated negative investigations, and heavy socioeconomic costs including healthcare utilization and the burden of loss of working days due to illness.[100](#nmo13573-bib-0100){ref-type="ref"} Hence, patients with CAPS often exhibit consequences of fear avoidance and characteristics including pain catastrophizing, hypervigilance, and attentional bias and psychological inflexibility, factors which make a compelling case for treatment of CAPS with gut‐focused hypnotherapy.[102](#nmo13573-bib-0102){ref-type="ref"} While specific evidence for hypnotherapy in CAPS is lacking in the adult literature, it has been shown to be effective in children.[70](#nmo13573-bib-0070){ref-type="ref"}

7. AREAS FOR FUTURE RESEARCH AND DEVELOPMENT {#nmo13573-sec-0016}
============================================

In this paper, we have already presented the compelling case for hypnotherapy and have summarized its benefits and limitations in Table [1](#nmo13573-tbl-0001){ref-type="table"}. Despite the mounting evidence for hypnotherapy in FGIDs, one of the challenges is optimizing access to services in already resource‐stretched healthcare systems. To address some of these challenges, it is recognized that there is a need to trial novel platforms of delivery, in order to provide wider‐scale access to this highly effective treatment. Group delivery of gut‐focused hypnotherapy is one potential way of achieving this aim. In a randomized controlled trial of the group approach compared to standard medical treatment, group hypnotherapy has been shown to be effective (61% vs. 41%), with durable effects being maintained over a year posttreatment. Moreover, while preliminary data from two recently completed randomized head to head trials have shown marginally better response rates in individualized vs. group hypnotherapy, both trials found that group therapy was not significantly inferior to individualized therapy,[103](#nmo13573-bib-0103){ref-type="ref"}, [104](#nmo13573-bib-0104){ref-type="ref"} suggesting that group hypnotherapy may be a way of improving access. One of the drawbacks of group hypnotherapy is that the package has to be generic, whereas for the more severe, refractory cases seen in tertiary care, who have more complex needs, treatment needs to be individualized. Consequently, group hypnotherapy would be ideal for primary care where a visiting hypnotherapist could treat large numbers of patients at a number of different practices. Furthermore, this would have the added advantage that the group, who would all come from one locality, could potentially support each other. Another challenge facing tertiary services is that the outcomes for gut‐focused hypnosis appear to be better in highly specialized research centers rather than in smaller community settings.[106](#nmo13573-bib-0106){ref-type="ref"} The exact reasons for these differences are unclear but may be due to differences in the training of therapists.[107](#nmo13573-bib-0107){ref-type="ref"} Another reason for apparent differences in outcomes may be due to differences in symptom severity and patient characteristics between tertiary patients treated in highly specialized centers and those treated in non‐specialized centers. For example, there is reasonably good evidence to suggest that hypnotherapy is effective in the refractory group of IBS patients seen in tertiary care and the UK National Institute for Health and Care Excellence (NICE) recommends this form of treatment in patients not responding to pharmacological and dietary interventions. Within this group of tertiary care patients, those with higher symptom severity scores tend to respond better and this is probably because such patients have a much more complex form of the disorder with additional psychological factors contributing. Furthermore, these patients are more likely to fully engage in this time‐consuming form of treatment, which is often perceived as their last chance to improve. Nonetheless, given that there are relatively few highly specialized centers, there is now an acute need for specialist centers to be able to provide effective hypnotherapy to patients further afield. Telemedicine is an emerging concept as a result of recent technological advances and is an attractive potential solution for this problem. Indeed, Skype gut‐focused hypnotherapy has been recently trialed in Manchester with some success. This approach resulted in a clinically significant reduction in IBS symptoms in 65% of twenty IBS patients treated with 12 sessions of hypnotherapy which included only one face to face, introductory session.[108](#nmo13573-bib-0108){ref-type="ref"} These results are promising and only slightly less effective (65% vs. 76%) than traditional face to face hypnotherapy outcomes from 1,000 consecutive patients at the same center.[74](#nmo13573-bib-0074){ref-type="ref"}, [108](#nmo13573-bib-0108){ref-type="ref"} A particular advantage of Skype hypnotherapy was that it did ensure that patients, who would otherwise have been unable to attend for face to face hypnotherapy, were able to access effective treatment within the comfort of their own home.

###### 

The benefits and limitations of gut‐focused hypnotherapy for functional gastrointestinal disorders

  Benefits                                                                                                                                                                                                                                                                                                                                     Limitations
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Extremely safeHighly effective even in otherwise refractory casesImprovement in extra‐intestinal symptomsReduces healthcare utilizationSocioeconomic benefits including reduced absenteeismReduced need for medicationImproves resilience and teaches self‐management skillsImproves quality of life, psychological and cognitive function   Time intensive (6--12, 60‐min sessions)Needs to be practiced at home regularly, at least initiallyRequirement for trained therapistMisconceptions and negative perceptionsRelatively expensiveLimited availability outside tertiary centersRequires highly motivated patients
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Furthermore, in order to manage finite resources such as gut‐focused hypnotherapy clinics, there is a need for a randomized dose‐response study, which is currently lacking, to help determine the optimal number of sessions. Current practice varies in terms of the number of sessions being offered in different centers. This is usually somewhere between 6 and 12 weekly sessions. Interestingly, while one study has shown that response at week 6 is predictive of a favorable response at week 12,[109](#nmo13573-bib-0109){ref-type="ref"} outcomes from a trial of 6 sessions of hypnotherapy have not shown the same long‐term effects seen with 12 sessions, suggesting that the effects of shorter courses of hypnotherapy may wear off over time.[85](#nmo13573-bib-0085){ref-type="ref"}, [89](#nmo13573-bib-0089){ref-type="ref"} However, from experience in other behavioral neurogastroenterology interventions such as pelvic floor biofeedback therapy, it is likely that one size will not fit all when it comes to follow‐up. Male patients in particular and those with the most severe symptoms are likely to require more sessions, whereas highly motivated individuals including those who spend longer doing self practice at home may achieve better outcomes after fewer sessions.[110](#nmo13573-bib-0110){ref-type="ref"}, [111](#nmo13573-bib-0111){ref-type="ref"} Further studies to better understand predictive factors to successful hypnotherapy outcomes[112](#nmo13573-bib-0112){ref-type="ref"} will, therefore, help customize the intensity of treatment, reduce dropout rates and improve resource management. In addition to gut‐focused hypnotherapy, there are several other promising behavioral treatments such as cognitive behavioral therapy with level 1 evidence in FGIDs.[24](#nmo13573-bib-0024){ref-type="ref"} These techniques, while beyond the scope of this article, are worthy of consideration, especially when hypnotherapy is not available. Unfortunately, to date, there are no published comparative studies between these other behavioral treatments and hypnotherapy, which should be the subject of future research. Finally, as detailed in this review, gut‐focused hypnotherapy has only been evaluated in several of the 33 described FGIDs, and therefore, future studies may explore its efficacy in other rarer FGIDs with overlapping pathophysiology.

8. CONCLUSIONS {#nmo13573-sec-0017}
==============

Gut‐focused hypnotherapy is a highly adaptable and effective treatment for refractory FGIDs which can be customized to the patient\'s symptoms. Not only has it consistently been shown to be superior to standard medical care, hypnosis has the added advantages of improving extra‐intestinal symptoms of FGIDs, improving psychological, cognitive function, and quality of life, and reducing healthcare utilization. Gastroenterologists should, therefore, seriously consider referral for hypnotherapy in patients with refractory FGIDs.
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